Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study.
J Med Genet
; 2023 Nov 08.
Article
in En
| MEDLINE
| ID: mdl-37940383
Full text:
1
Database:
MEDLINE
Language:
En
Year:
2023
Type:
Article